Advanced search
Publication Cover
Epigenomics Volume 13, 2021 - Issue 24
Submit an article Journal homepage
146
Views
0
CrossRef citations to date
0
Altmetric
Editorial

mRNA Modifications: Clinical Clarification and Significance

Kan Pan1 First Clinical College, Wenzhou Medical University, Wenzhou, 325035, ChinaView further author information
,
Gangqiang Guo2 Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research & Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens & Immunity, Department of Microbiology & Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8031-7937View further author information
ORCID Icon &
Xiangyang Xue2 Wenzhou Collaborative Innovation Center of Gastrointestinal Cancer in Basic Research & Precision Medicine, Wenzhou Key Laboratory of Cancer-related Pathogens & Immunity, Department of Microbiology & Immunology, Institute of Molecular Virology and Immunology, Institute of Tropical Medicine, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, 325035, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8670-2016View further author information
ORCID Icon
Pages 1901-1903 | Received 11 Sep 2021, Accepted 27 Sep 2021, Published online: 22 Oct 2021

References

  • Zhao BS , RoundtreeIA , HeC. Post-transcriptional gene regulation by mRNA modifications. Nat. Rev. Mol. Cell Biol.18(1), 31–42 (2017).
  • Jin G , XuM , ZouM , DuanS. The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol. Ther. Nucleic Acids20, 13–24 (2020).
  • Davalos V , BlancoS , EstellerM. SnapShot: messenger RNA modifications. Cell174(2), 498–498e491 (2018).
  • Jonkhout N , TranJ , SmithMA , SchonrockN , MattickJS , NovoaEM. The RNA modification landscape in human disease. RNA23(12), 1754–1769 (2017).
  • Liang W , LinZ , DuC , QiuD , ZhangQ. mRNA modification orchestrates cancer stem cell fate decisions. Mol. Cancer19(1), 38 (2020).
  • Wang J , WangJ , GuQet al. The biological function of m6A demethylase ALKBH5 and its role in human disease. Cancer Cell Int.20, 347 (2020).
  • Dimitrova DG , TeyssetL , CarreC. RNA 2′-O-methylation (Nm) modification in human diseases. Genes (Basel)10(2), (2019).
  • Nombela P , Miguel-LopezB , BlancoS. The role of m(6)A, m(5)C and Psi RNA modifications in cancer: novel therapeutic opportunities. Mol. Cancer20(1), 18 (2021).
  • Barbieri I , KouzaridesT. Role of RNA modifications in cancer. Nat. Rev. Cancer20(6), 303–322 (2020).
  • Blanco S , BandieraR , PopisMet al. Stem cell function and stress response are controlled by protein synthesis. Nature534(7607), 335–340 (2016).
  • Guo G , WangH , ShiXet al. Disease activity-associated alteration of mRNA m(5) C methylation in CD4(+) T cells of systemic lupus erythematosus. Front Cell Dev. Biol.8, 430 (2020).
  • Chen YS , OuyangXP , YuXHet al. N6-adenosine methylation (m(6)A) RNA Modification: an emerging role in cardiovascular diseases. J. Cardiovasc. Transl. Res.14(5), 857–872 (2021).
  • Jung Y , GoldmanD. Role of RNA modifications in brain and behavior. Genes Brain Behav.17(3), e12444 (2018).
  • Zhang C , JiaG. Reversible RNA modification N(1)-methyladenosine (m(1)A) in mRNA and tRNA. Genomics Proteomics Bioinformatics16(3), 155–161 (2018).
  • Chen YT , ShenJY , ChenDPet al. Identification of cross-talk between m(6)A and 5mC regulators associated with onco-immunogenic features and prognosis across 33 cancer types. J. Hematol. Oncol.13(1), 22 (2020).
  • Cully M . Chemical inhibitors make their RNA epigenetic mark. Nat. Rev. Drug Discov.18(12), 892–894 (2019).
  • Qing Y , DongL , GaoLet al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m(6)A/PFKP/LDHB axis. Mol. Cell81(5), 922–939e929 (2021).
  • Reautschnig P , VogelP , StafforstT. The notorious R.N.A. in the spotlight – drug or target for the treatment of disease. RNA Biol.14(5), 651–668 (2017).
  • Kormann MS , HasenpuschG , AnejaMKet al. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice. Nat. Biotechnol.29(2), 154–157 (2011).
  • Anreiter I , MirQ , SimpsonJTet al. New twists in detecting mRNA modification dynamics. Trends Biotechnol.39(1), 72–89 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.